109 related articles for article (PubMed ID: 24942538)
1. Genome-wide mapping of miRNAs expressed in embryonic stem cells and pluripotent stem cells generated by different reprogramming strategies.
Zhao B; Yang D; Jiang J; Li J; Fan C; Huang M; Fan Y; Jin Y; Jin Y
BMC Genomics; 2014 Jun; 15(1):488. PubMed ID: 24942538
[TBL] [Abstract][Full Text] [Related]
2. Changes in microRNA expression during differentiation of embryonic and induced pluripotent stem cells to definitive endoderm.
Francis N; Moore M; Asan SG; Rutter GA; Burns C
Gene Expr Patterns; 2015; 19(1-2):70-82. PubMed ID: 26277621
[TBL] [Abstract][Full Text] [Related]
3. Incomplete reprogramming of DNA replication timing in induced pluripotent stem cells.
Edwards MM; Wang N; Massey DJ; Bhatele S; Egli D; Koren A
Cell Rep; 2024 Jan; 43(1):113664. PubMed ID: 38194345
[TBL] [Abstract][Full Text] [Related]
4. Incomplete Reprogramming of DNA Replication Timing in Induced Pluripotent Stem Cells.
Edwards MM; Wang N; Massey DJ; Egli D; Koren A
bioRxiv; 2023 Jun; ():. PubMed ID: 37398435
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation dynamics in human induced pluripotent stem cells over time.
Nishino K; Toyoda M; Yamazaki-Inoue M; Fukawatase Y; Chikazawa E; Sakaguchi H; Akutsu H; Umezawa A
PLoS Genet; 2011 May; 7(5):e1002085. PubMed ID: 21637780
[TBL] [Abstract][Full Text] [Related]
6. Pluripotent stem cells with low differentiation potential contain incompletely reprogrammed DNA replication.
Paniza T; Deshpande M; Wang N; O'Neil R; Zuccaro MV; Smith ME; Madireddy A; James D; Ecker J; Rosenwaks Z; Egli D; Gerhardt J
J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32673399
[TBL] [Abstract][Full Text] [Related]
7. Equine Induced Pluripotent Stem Cell Culture.
Falk J; Donadeu FX
Methods Mol Biol; 2024; 2749():175-184. PubMed ID: 38133784
[TBL] [Abstract][Full Text] [Related]
8. Low pH reprograms somatic murine cells into pluripotent stem cells: a novel technique with therapeutic implications.
Williams JS; Xiao Y; Brownell I
Cancer Biol Ther; 2014 Jun; 15(6):675-7. PubMed ID: 24618709
[TBL] [Abstract][Full Text] [Related]
9. Novel glycylated sugar alcohols protect ESC-specific microRNAs from degradation in iPS cells.
Chang-Lin S; Hung A; Chang DC; Lin YW; Ying SY; Lin SL
Nucleic Acids Res; 2016 Jun; 44(10):4894-906. PubMed ID: 27001514
[TBL] [Abstract][Full Text] [Related]
10. Reliable multiplex generation of pooled induced pluripotent stem cells.
Smullen M; Olson MN; Reichert JM; Dawes P; Murray LF; Baer CE; Wang Q; Readhead B; Church GM; Lim ET; Chan Y
Cell Rep Methods; 2023 Sep; 3(9):100570. PubMed ID: 37751688
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil generation from hematopoietic progenitor cells and induced pluripotent stem cells (iPSCs): potential applications.
Jafarzadeh A; Motaghi M; Patra SK; Jafarzadeh Z; Nemati M; Saha B
Cytotherapy; 2024 Mar; ():. PubMed ID: 38625068
[TBL] [Abstract][Full Text] [Related]
12. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways.
Hassan G; Ohara T; Afify SM; Kumon K; Zahra MH; Fu X; Al Kadi M; Seno A; Salomon DS; Seno M
J Exp Clin Cancer Res; 2022 Jan; 41(1):29. PubMed ID: 35063003
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders.
Vaccarino FM; Stevens HE; Kocabas A; Palejev D; Szekely A; Grigorenko EL; Weissman S
Neuropharmacology; 2011 Jun; 60(7-8):1355-63. PubMed ID: 21371482
[TBL] [Abstract][Full Text] [Related]
14. Insights into the development of insulin-producing cells: Precursors correlated involvement of microRNA panels.
Pierantoni M; Grassilli S; Brugnoli F; Dell'Aira M; Bertagnolo V
Life Sci; 2024 Jun; 350():122762. PubMed ID: 38843994
[TBL] [Abstract][Full Text] [Related]
15. Sendai virus persistence questions the transient naive reprogramming method for iPSC generation.
De Los Angeles A; Hug CB; Gladyshev VN; Church GM; Velychko S
bioRxiv; 2024 Mar; ():. PubMed ID: 38559172
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks.
Martin U
Front Med (Lausanne); 2017; 4():229. PubMed ID: 29312943
[TBL] [Abstract][Full Text] [Related]
17. RNA Genes: Retroelements and Virally Retroposable microRNAs in Human Embryonic Stem Cells.
Fujii YR
Open Virol J; 2010 May; 4():63-75. PubMed ID: 20835360
[TBL] [Abstract][Full Text] [Related]
18. Gene-manipulated embryonic stem cells for rat transgenesis.
Kawamata M; Ochiya T
Cell Mol Life Sci; 2011 Jun; 68(11):1911-5. PubMed ID: 21437643
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-triggered three dimensional hyaluronic acid hydrogel promotes in vitro and in vivo reprogramming into induced pluripotent stem cells.
Kim D; Lee MJ; Arai Y; Ahn J; Lee GW; Lee SH
Bioact Mater; 2024 Aug; 38():331-345. PubMed ID: 38764447
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-based system in stem cell reprogramming; differentiation/dedifferentiation.
Pourrajab F; Babaei Zarch M; BaghiYazdi M; Hekmatimoghaddam S; Zare-Khormizi MR
Int J Biochem Cell Biol; 2014 Oct; 55():318-28. PubMed ID: 25150833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
